サワイグループホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/03/05 | 2,091.5 | 2,128 | 2,071.5 | 2,104 | +47 | +2.3% | 848,900 |
2025/03/04 | 2,053 | 2,079 | 2,025 | 2,057 | +94 | +4.8% | 1,041,400 |
2025/03/03 | 1,983 | 2,025.5 | 1,961 | 1,963 | +56 | +2.9% | 833,900 |
2025/02/28 | 1,978 | 1,980 | 1,890 | 1,907 | -78.5 | -4% | 1,164,100 |
2025/02/27 | 2,036.5 | 2,037 | 1,984.5 | 1,985.5 | -35.5 | -1.8% | 462,800 |
2025/02/26 | 2,041.5 | 2,048 | 1,982 | 2,021 | -6.5 | -0.3% | 503,400 |
2025/02/25 | 2,023.5 | 2,042.5 | 2,022 | 2,027.5 | +4 | +0.2% | 444,600 |
2025/02/21 | 2,059 | 2,060.5 | 2,017.5 | 2,023.5 | -35.5 | -1.7% | 383,600 |
2025/02/20 | 2,061.5 | 2,069 | 2,038 | 2,059 | -3 | -0.1% | 516,700 |
2025/02/19 | 2,078.5 | 2,102 | 2,046 | 2,062 | -3.5 | -0.2% | 489,000 |
2025/02/18 | 2,083.5 | 2,091.5 | 2,064.5 | 2,065.5 | -23.5 | -1.1% | 589,000 |
2025/02/17 | 2,080 | 2,170 | 2,075.5 | 2,089 | +39 | +1.9% | 1,071,000 |
2025/02/14 | 1,934.5 | 2,084.5 | 1,913 | 2,050 | +132 | +6.9% | 1,739,300 |
2025/02/13 | 1,885.5 | 1,918 | 1,883.5 | 1,918 | +32.5 | +1.7% | 796,900 |
2025/02/12 | 1,895 | 1,900 | 1,851.5 | 1,885.5 | -12 | -0.6% | 894,700 |
2025/02/10 | 1,893 | 1,897.5 | 1,885 | 1,897.5 | +0.5 | ±0% | 396,700 |
2025/02/07 | 1,900 | 1,908 | 1,888 | 1,897 | -31 | -1.6% | 699,100 |
2025/02/06 | 1,913.5 | 1,938.5 | 1,910 | 1,928 | +10.5 | +0.5% | 729,800 |
2025/02/05 | 1,900 | 1,917.5 | 1,893 | 1,917.5 | +4.5 | +0.2% | 718,400 |
2025/02/04 | 1,964 | 1,964 | 1,906 | 1,913 | -11 | -0.6% | 706,600 |
2025/02/03 | 1,991 | 1,995 | 1,914 | 1,924 | -87 | -4.3% | 1,122,300 |
2025/01/31 | 2,000 | 2,016 | 1,989 | 2,011 | +3.5 | +0.2% | 487,900 |
2025/01/30 | 2,004 | 2,026.5 | 1,998 | 2,007.5 | +3.5 | +0.2% | 442,200 |
2025/01/29 | 2,001 | 2,006 | 1,986.5 | 2,004 | ±0 | ±0% | 477,500 |
2025/01/28 | 2,034 | 2,040.5 | 1,996 | 2,004 | -27.5 | -1.4% | 605,200 |
2025/01/27 | 2,038.5 | 2,046 | 2,022 | 2,031.5 | +4.5 | +0.2% | 549,400 |
2025/01/24 | 2,038 | 2,044 | 2,019 | 2,027 | +13.5 | +0.7% | 764,700 |
2025/01/23 | 2,020 | 2,023.5 | 2,002 | 2,013.5 | -17 | -0.8% | 677,100 |
2025/01/22 | 2,036 | 2,051 | 2,020 | 2,030.5 | +5 | +0.2% | 591,200 |
2025/01/21 | 2,034 | 2,043 | 2,012 | 2,025.5 | +4.5 | +0.2% | 504,300 |
2025/01/20 | 2,015 | 2,031.5 | 2,002 | 2,021 | +6.5 | +0.3% | 647,100 |
2025/01/17 | 2,060 | 2,060 | 2,007 | 2,014.5 | -36 | -1.8% | 670,400 |
2025/01/16 | 2,128.5 | 2,143.5 | 2,038.5 | 2,050.5 | -59.5 | -2.8% | 941,700 |
2025/01/15 | 2,136.5 | 2,143.5 | 2,103 | 2,110 | -26.5 | -1.2% | 499,100 |
2025/01/14 | 2,180 | 2,183 | 2,114 | 2,136.5 | -48 | -2.2% | 881,100 |
2025/01/10 | 2,211 | 2,223 | 2,177.5 | 2,184.5 | -53 | -2.4% | 770,400 |
2025/01/09 | 2,187 | 2,250 | 2,176 | 2,237.5 | +112 | +5.3% | 1,149,700 |
2025/01/08 | 2,167.5 | 2,174 | 2,125.5 | 2,125.5 | -48.5 | -2.2% | 473,800 |
2025/01/07 | 2,132.5 | 2,199 | 2,130.5 | 2,174 | +30 | +1.4% | 657,900 |
2025/01/06 | 2,150 | 2,160.5 | 2,136.5 | 2,144 | -7 | -0.3% | 503,000 |
2024/12/30 | 2,170 | 2,181.5 | 2,151 | 2,151 | -12.5 | -0.6% | 364,500 |
2024/12/27 | 2,179 | 2,179 | 2,157.5 | 2,163.5 | +11.5 | +0.5% | 381,000 |
2024/12/26 | 2,159 | 2,166 | 2,129 | 2,152 | +13 | +0.6% | 363,900 |
2024/12/25 | 2,180 | 2,186.5 | 2,123 | 2,139 | -61.5 | -2.8% | 414,200 |
2024/12/24 | 2,175.5 | 2,234 | 2,162.5 | 2,200.5 | +20 | +0.9% | 774,000 |
2024/12/23 | 2,178.5 | 2,202 | 2,161.5 | 2,180.5 | +2 | +0.1% | 862,300 |
2024/12/20 | 2,090 | 2,193 | 2,090 | 2,178.5 | +128.5 | +6.3% | 1,216,500 |
2024/12/19 | 2,000 | 2,080 | 2,000 | 2,050 | +42 | +2.1% | 534,100 |
2024/12/18 | 2,020 | 2,039.5 | 1,998 | 2,008 | -17 | -0.8% | 505,700 |
2024/12/17 | 2,024.5 | 2,037 | 2,012.5 | 2,025 | -7.5 | -0.4% | 372,600 |
51~
100
件表示中 / 1010件
類似銘柄と比較する
現在ご覧いただいている「サワイGHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サワイGHD | 175,400円 | +5.9% | +24.5% | 3.14% | 11.64倍 | 1.10倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
日本新薬 | 340,100円 | +8.0% | -15.3% | 3.65% | 9.55倍 | 0.93倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 172,500円 | +5.0% | +1.5% | 0.00% | 14.75倍 | 3.93倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 388,500円 | +3.6% | +6.1% | 3.09% | 13.09倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム